Vaxxas grabs $20 mln Series B
Vaxxas, a developer of a next-generation vaccine delivery platform, has raised $20 million in Series B funding. The investors in this round were not named.
10 February 2015•3 mins read
Vaxxas, a developer of a next-generation vaccine delivery platform, has raised $20 million in Series B funding. The investors in this round were not named.
